A simple scoring system to predict early recurrence of Bismuth-Corlette type IV perihilar cholangiocarcinoma

被引:6
作者
Peng, Ding-Zhong [1 ]
Lu, Jiong [1 ]
Li, Bei [1 ]
Hu, Hai-Jie [1 ]
Ye, Xi-Wen [1 ]
Xiong, Xian-Ze [1 ]
Cheng, Nan-Sheng [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Biliary Surg, Chengdu, Sichuan, Peoples R China
来源
GASTROENTEROLOGY REPORT | 2019年 / 7卷 / 05期
关键词
early recurrence; Bismuth-Corlette classification; perihilar cholangiocarcinoma; LONG-TERM SURVIVAL; HILAR CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; INTRAHEPATIC RECURRENCE; LYMPHOVASCULAR INVASION; SURGICAL RESECTION; PROGNOSTIC-FACTORS; RISK-FACTORS; MANAGEMENT; GEMCITABINE;
D O I
10.1093/gastro/goz012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Early recurrence has been reported to be predictive of a poor prognosis for patients with perihilar cholangiocarcinoma (pCCA) after resection. The objective of our study was to construct a useful scoring system to predict early recurrence for Bismuth-Corlette type IV pCCA patients in clinic and to investigate the value of early recurrence in directing post-operative surveillance and adjuvant therapy. Methods: In total, 244 patients who underwent radical resection for type IV pCCA were included. Data on clinicopathological characteristics, perioperative details and survival outcomes were analyzed. Survival curves were generated using the Kaplan-Meier method. Univariate and multivariate logistic-regression models were used to identify factors associated with early recurrence. Results: Twenty-one months was defined as the cutoff point to distinguish between early and late recurrence. Univariate and multivariate analysis revealed that CA19-9 level >200 U/mL, R1 resection margin, higher N category and positive lymphovascular invasion were independent predictors of early recurrence. The scoring system was constructed accordingly. The early-recurrence rates of patients with scores of 0, 1, 2, 3, 4, and 5 were 23.9%, 38.7%, 60.0%, 78.6%, 83.4%, and 100%, respectively. Adjuvant therapy was significantly associated with higher overall survival rate for patients with early recurrence, but not for those with late recurrence. Patients in the early-recurrence group with scores >= 2 had better prognoses after adjuvant therapy. Conclusions: A simple scoring system using CA19-9 level, N category, resection margin and lymphovascular invasion status could predict early recurrence, and thus might direct post-operative surveillance and adjuvant therapy for patients with type IV pCCA.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 46 条
  • [1] Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: Prognostic factors and longterm outcomes
    Baton, Olivier
    Azoulay, Daniel
    Adam, Delvart V. Rene
    Castaing, Denis
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (02) : 250 - 260
  • [2] Extrahepatic Bile Duct Adenocarcinoma: Patients at High-Risk for Local Recurrence Treated with Surgery and Adjuvant Chemoradiation Have an Equivalent Overall Survival to Patients with Standard-Risk Treated with Surgery Alone
    Borghero, Yerko
    Crane, Christopher H.
    Szklaruk, Janio
    Oyarzo, Mauricio
    Curley, Steven
    Pisters, Peter W.
    Evans, Douglas
    Abdalla, Eddie K.
    Thomas, Melanie B.
    Das, Prajnan
    Wistuba, Ignacio I.
    Krishnan, Sunil
    Vauthey, Jean-Nicolas
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 3147 - 3156
  • [3] Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma
    Cadamuro, Massimiliano
    Spagnuolo, Gaia
    Sambado, Luisa
    Indraccolo, Stefano
    Nardo, Giorgia
    Rosato, Antonio
    Brivio, Simone
    Caslini, Chiara
    Stecca, Tommaso
    Massani, Marco
    Bassi, Nicolo
    Novelli, Eugenio
    Spirli, Carlo
    Fabris, Luca
    Strazzabosco, Mario
    [J]. CANCER RESEARCH, 2016, 76 (16) : 4775 - 4784
  • [4] MANAGEMENT OF PROXIMAL CHOLANGIOCARCINOMAS BY SURGICAL RESECTION AND RADIOTHERAPY
    CAMERON, JL
    PITT, HA
    ZINNER, MJ
    KAUFMAN, SL
    COLEMAN, J
    [J]. AMERICAN JOURNAL OF SURGERY, 1990, 159 (01) : 91 - 98
  • [5] Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Chen, Tao
    Zhang, Min-Gui
    Xu, Hua-Xiang
    Wang, Wen-Quan
    Liu, Liang
    Yu, Xian-Jun
    [J]. MEDICINE, 2015, 94 (19)
  • [6] Predictive factors for prognosis of hilar cholangiocarcinoma: Postresection radiotherapy improves survival
    Cheng, Q.
    Luo, X.
    Zhang, B.
    Jiang, X.
    Yi, B.
    Wu, M.
    [J]. EJSO, 2007, 33 (02): : 202 - 207
  • [7] Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas
    Choi, CW
    Choi, IK
    Seo, JH
    Kim, BS
    Kim, JS
    Kim, CD
    Um, SH
    Kim, JS
    Kim, YH
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04): : 425 - 428
  • [8] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [9] Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
    Ducreux, M
    Rougier, P
    Fandi, A
    Clavero-Fabri, MC
    Villing, AL
    Fassone, F
    Fandi, L
    Zarba, J
    Armand, JP
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (06) : 653 - 656
  • [10] Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas
    Ebata, T.
    Kosuge, T.
    Hirano, S.
    Unno, M.
    Yamamoto, M.
    Miyazaki, M.
    Kokudo, N.
    Miyagawa, S.
    Takada, T.
    Nagino, M.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 (02) : 79 - 88